期刊文献+

通脉化浊汤治疗痰瘀互结型冠心病的临床疗效分析

下载PDF
导出
摘要 目的:探究通脉化浊汤在痰瘀互结型冠心病患者中的治疗效果。方法:选择2012年04月--2014年04月在我院接受治疗的90例痰瘀互结冠心痛患者作为研究对象,把这些患者平均分成两组,一组接受西药治疗,为对照组,一组在西药基础上使用通脉化浊汤治疗,为观察组,对比西药和通脉化浊汤的治疗效果。结果:对照组患者的心绞痛治疗总有效率为82.2%,观察组患者的心绞痛治疗总有效率为93.3%。观察组的治疗效果明显优于对照组。观察组和对照组差异存在统计学意义(P〈0.05)。对照组患者的心电图治疗总有效率为84.4%,观察组患者的心绞痛治疗总有效率为95.6%。观察组的治疗效果明显优于对照组。观察组和对照组差异存在统计学意义(P〈0.05)。结论:痰瘀互结型冠心痛患者的治疗中,通脉化浊汤能获得良好的效果,值得在临床上推广。
作者 张云峰
出处 《药物与人》 2014年第6期152-152,共1页 Medicine & People
  • 相关文献

参考文献4

二级参考文献23

  • 1陶寿琪.缺血性心脏的命名及诊断标准.中华心血管病杂志,2000,.
  • 2Samani NJ, Erdmann J, Hall AS, et al. Genome wide association analysis of coronary artery disease [J]. N Engl J Med, 2007, 357 (5): 443-453.
  • 3Ashavaid TF, Shalia KK, Kondkar AA, et al. Gene polymor- phism and coronary risk factors in Indian populations [J]. Clin Chem LabMed, 2002, 40 (10): 975-985.
  • 4Maki KC, Davidson MH, Dicklin MR, et al. Predictors of ante- rior and posterior wall earotid intima media thiekness progression in men and women at moderate risk of eoronary heart disease [J]- J Clin Lipidol, 2011, 5 (3): 141-151.
  • 5Adak M, Shivapuri JN. Serum lipid and lipoprotein profile abnor- mality in predicting the risk of coronary artery disease in non-di- abetic patients attending NMCTH, Birgunj [J]. Nepal Med Coil J, 2010, 12 (3): 158-164.
  • 6Liu YL, Qian HX, Qin L, et al. Serum LDL-C and LDL-C/ HDL-C ratio are positively correlated to lymph node stages in males with eo|oreetal cancer [J]. Hepatogastroenterology, 2011, 58 (106): 883-387.
  • 7Patel A, Barzi P, Jamrozik K, et al. Serum triglyeerides as a risk factor for cardiovascular diseases in the Asia-Pacific region [J]. Circulation, 2004, 110 (17) : 2678-2686.
  • 8Sarwar N, Danesh J Eiriksdottir G, et al. Triglyeerides and the risk of coronary heart disease: 10 158 incident cases among 262 525 participants in 29 western prospective studies [J]. Circula- tion, 2007, 115 (4): 450-458.
  • 9Watts GF, Karpe F. Triglycerides and atberogenic dyslipidae- mia: extending treatment beyond statins in the high-risk cardi- ovascular patient [J]. Heart, 2011, 97 (5): 350-356.
  • 10Nag SS, Daniel GW, Bullann MF, et al. LDL-C goal attainment among patients newly diagnosed with coronary heart disease or diabetes in a commercial HMO [J]. J Manag Care Pharm, 2007, 13 (8) 652-663.

共引文献147

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部